Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Drug Retailers Should Promote Self-medication: NMRA Meeting
October 7, 2002
- Korosho to Reorganize PFSB
October 7, 2002
- DIAGNOSTIC NEWS IN BRIEF
October 7, 2002
- Mr Miyauchi Criticizes Korosho for Its Opposition to Deregulation
October 7, 2002
- Nippon Keidanren Calls For Simplification of Application for Medical Devices
October 7, 2002
- PFSB to Accelerate Introduction of Fast-Track System
October 7, 2002
- Olympus Sets Up Marketing Subsidiary in Sao Paulo
October 7, 2002
- Drugs for 21st Quality Reevaluation Announced
October 7, 2002
- Olympus: New Reaction/Analysis System FD10
October 7, 2002
- Results of Reexamination for 22 Active Ingredients Announced
October 7, 2002
- Baxter Transfers Cardiovascular Products to Edwards Lifesciences in Japan
October 7, 2002
- DIA Conference on Pharmaceutical Evolution in Asia
October 7, 2002
- New Chugai Inaugurated
October 7, 2002
- Relief of Lower Back Pain Increases Patients' Satisfaction with Osteoporosis Drugs
October 7, 2002
- WORLD NEWS IN BRIEF
October 7, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
October 7, 2002
- ENGLISH BOOK
October 7, 2002
- Maurer's Healthcare Insight (34)
October 7, 2002
- BULLETIN
October 7, 2002
- JP Should Be in Greater Harmony with Pharmacopoeias from Other Countries: Seminar
October 7, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…